Aoxing Pharmaceutical Company Inc (AOXG)

Aoxing Pharmaceutical Company, Inc. is a healthcare company listed on OTC Markets as common stock under the ticker AOXG. The company focuses on the research, development, manufacture, and distribution of pharmaceutical products for narcotic pain management and addiction treatment, with its business centered primarily in the People’s Republic of China. Its marketed products include Zhongtong'an, a herbal extraction capsule for oral and dental pain; Yiqi Qiangshen Granule, an OTC herbal product used to support bodily strength and circulation; and Tilidine hydrochloride, a synthetic narcotic analgesic tablet used for acute, moderate to severe pain and cancer-related pain. The company’s development pipeline includes Oxycodone and Acetaminophen tablets and capsules, Buprenorphine/Naloxone sublingual tablets for opioid dependence, and Tilidine/Naloxone capsules for pain treatment. Formerly known as China Aoxing Pharmaceutical Company, Inc., the company adopted its current name in March 2010 and is based in Foster City, California.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.